ADHD

Latest News


CME Content


Children exposed to ischemic-hypoxic events in utero are at increased risk of developing attention-deficit/hyperactivity disorder (ADHD), especially those born prematurely. The findings add to growing evidence that both prenatal and postnatal factors affect neurodevelopment.

The US Food and Drug Administration (FDA) has approved extended-release methylphenidate hydrochloride oral suspension for the treatment of attention-deficit/hyperactivity disorder (ADHD). Efficacy was determined in a randomized, double-blind, crossover study that showed improvement for both attention and behavior metrics for up to 12 hours in children aged 6 to 12 years diagnosed with ADHD compared with placebo. The once-daily treatment will be available in January 2013.

A study of Canadian children found that the youngest children in the class are significantly more likely to be diagnosed with attention-deficit/hyperactivity disorder (ADHD) and prescribed medication than their peers in the same grade. Find out why overdiagnosis and overprescribing are a concern.

Results of a survey of AAP members show that most US pediatricians bypass an ECG before starting children on stimulant medication for ADHD, opting for a routine cardiac history and physical examination instead. Find out how perceived barriers to cardiac screening influence clinical practice.

Evaluations for attention-deficit/hyperactivity disorder (ADHD) should begin in children at 4 years and continue until 18 years, which significantly expands the age range for recommended screening. Released at the American Academy of Pediatrics National Conference in Boston, Massachusetts, the clinical practice guidelines recommend behavioral interventions as the first-line treatment in preschool children. The guidelines also have some new suggestions related to methylphenidate treatment for children younger than 6 years.

Here?s some new information that can help when you?re determining whom to screen for attention-deficit/hyperactivity disorder: ADHD prevalence has increased to 10% for children with family income less than 100% of the poverty level and to 11% for those with family income between 100% and 199% of the poverty level compared with a 7% to 9% overall increase, according to a National Center for Health Statistics report. Read more to find out what other indicators were linked with above-average increases in the disorder?s prevalence.

This 1-year-old African-American boy is being followed for developmental delays. His 35-year-old mother has no known health problems, and this was her third pregnancy.Premature delivery at 27 weeks was uncomplicated, yielding appropriate birth weight and Dubowitz scores for gestational age.

Findings of a population-based cohort study indicate that a low Apgar score at 5 minutes in newborns is associated with a higher risk of attention-deficit/hyperactivity disorder (ADHD) in childhood.

In a conference last week, President Obama announced a new Web site http://stopbullying.gov to help raise awareness about the issue. This is part of an effort to encourage cooperation between government agencies and educators to protect children from bullying based on race, ethnicity, disability, or sexuality. Are you an advocate for prevention? Share your antibullying efforts with colleagues.

Two-thirds of children with attention-deficit/hyperactivity disorder (ADHD) have comorbid mental health or neurodevelopment disorders, according to a large survey reported online in Pediatrics.